Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CEP-8983 |
Trade Name | |
Synonyms | |
Drug Descriptions |
CEP-8983 inhibits PARP1 and PARP2, potentially resulting in decreased tumor cell viability and increased sensitivity to DNA damaging agents (PMID: 24439051, PMID: 23428903). |
DrugClasses | PARP Inhibitor (Pan) 31 |
CAS Registry Number | 374071-46-2 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CEP-8983 | CEP-8983 | 0 | 0 |
CEP-8983 + Cisplatin | CEP-8983 Cisplatin | 2 | 0 |